Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 435 | 303 | 346 | 2,061 | 3,959 |
| Depreciation Amortization | 740 | 497 | 245 | 1,026 | 779 |
| Income taxes - deferred | -15 | -212 | 339 | 642 | 1,499 |
| Accounts receivable | -7,629 | -5,986 | -2,927 | -6,692 | -3,630 |
| Accounts payable and accrued liabilities | 1,648 | 1,200 | 438 | -2,207 | -2,445 |
| Other Working Capital | -7,876 | -3,439 | -941 | -5,527 | -8,904 |
| Other Operating Activity | 9,902 | 7,860 | 2,635 | 10,162 | 6,775 |
| Operating Cash Flow | $-2,794 | $223 | $135 | $-535 | $-1,966 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -9 | -2 | -118 | -96 |
| Investing Cash Flow | $-9 | $-9 | $-2 | $-118 | $-96 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,183 | N/A | N/A | -437 | -350 |
| Debt Issued | N/A | N/A | N/A | 645 | 1,349 |
| Debt Repayment | N/A | N/A | N/A | N/A | -470 |
| Common Stock Issued | N/A | N/A | N/A | 2,739 | 2,739 |
| Financing Cash Flow | $3,183 | $N/A | $N/A | $2,947 | $3,268 |
| Exchange Rate Effect | -212 | -278 | 11 | -753 | -530 |
| Beginning Cash Position | 6,912 | 6,912 | 6,912 | 5,372 | 5,372 |
| End Cash Position | 7,081 | 6,849 | 7,056 | 6,912 | 6,046 |
| Net Cash Flow | $168 | $-63 | $144 | $1,541 | $675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,794 | 223 | 135 | -535 | -1,966 |
| Capital Expenditure | -9 | -9 | -2 | -118 | -96 |
| Free Cash Flow | -2,803 | 214 | 133 | -653 | -2,062 |